DocuSign, Inc. (NASDAQ:DOCU) Shares Acquired by Harvest Fund Management Co. Ltd

Harvest Fund Management Co. Ltd lifted its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 307.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 20,075 shares of the company’s stock after acquiring an additional 15,149 shares during the quarter. Harvest Fund Management Co. Ltd’s holdings in DocuSign were worth $1,795,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. State Street Corp lifted its position in shares of DocuSign by 2.3% during the 3rd quarter. State Street Corp now owns 5,372,939 shares of the company’s stock valued at $333,604,000 after acquiring an additional 120,743 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of DocuSign by 1.6% during the third quarter. Geode Capital Management LLC now owns 3,483,184 shares of the company’s stock valued at $215,789,000 after purchasing an additional 53,554 shares during the last quarter. Thrivent Financial for Lutherans boosted its position in shares of DocuSign by 1.8% in the 4th quarter. Thrivent Financial for Lutherans now owns 2,318,137 shares of the company’s stock valued at $208,494,000 after purchasing an additional 40,825 shares during the period. FMR LLC boosted its position in shares of DocuSign by 16.8% in the 3rd quarter. FMR LLC now owns 2,192,885 shares of the company’s stock valued at $136,156,000 after purchasing an additional 315,073 shares during the period. Finally, Bank of New York Mellon Corp boosted its position in shares of DocuSign by 61.5% in the 4th quarter. Bank of New York Mellon Corp now owns 1,673,612 shares of the company’s stock valued at $150,525,000 after purchasing an additional 637,505 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Price Performance

DOCU opened at $85.61 on Thursday. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86. The business has a 50-day moving average of $87.67 and a 200-day moving average of $79.91. The company has a market capitalization of $17.30 billion, a PE ratio of 17.65, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02.

DocuSign (NASDAQ:DOCU) last posted its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.02. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The company had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. During the same period last year, the business earned $0.76 EPS. The business’s quarterly revenue was up 9.0% on a year-over-year basis. On average, equities research analysts expect that DocuSign, Inc. will post 1.17 earnings per share for the current fiscal year.

Insider Transactions at DocuSign

In other news, Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the completion of the sale, the director now directly owns 8,270 shares of the company’s stock, valued at $722,880.70. This trade represents a 6.07 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Allan C. Thygesen sold 40,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total value of $3,601,600.00. Following the completion of the transaction, the chief executive officer now directly owns 156,050 shares in the company, valued at $14,050,742. The trade was a 20.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 66,034 shares of company stock valued at $5,932,352 in the last three months. Corporate insiders own 1.66% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on DOCU shares. Bank of America decreased their price target on DocuSign from $112.00 to $98.00 and set a “neutral” rating for the company in a research report on Friday, March 14th. Jefferies Financial Group increased their price target on DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Hsbc Global Res upgraded DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. HSBC reiterated a “reduce” rating on shares of DocuSign in a research report on Friday, December 6th. Finally, JPMorgan Chase & Co. upgraded DocuSign from an “underweight” rating to a “neutral” rating and raised their price objective for the stock from $70.00 to $75.00 in a research report on Monday, March 10th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $95.00.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.